LITS is Lite Strategy, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.14. Market cap: $35M.
Stock snapshot
| Price | $1.14 |
| Market cap | $35M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About LITS
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Related non-dividend companies
Other non-dividend stocks investors research alongside LITS. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is LITS's current stock price?
LITS (Lite Strategy, Inc.) is currently trading at $1.14.
Does LITS pay a dividend?
LITS (Lite Strategy, Inc.) does not currently pay a regular dividend.
Track LITS in DiviDrip
Add LITS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search LITS and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.